Ganglionic Stimulants

"Ganglionic Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists.

Descriptor ID

D005731

MeSH Number(s)

D27.505.696.663.050.400

Concept/Terms

Ganglionic Stimulants

Below are MeSH descriptors whose meaning is more general than "Ganglionic Stimulants".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Peripheral Nervous System Agents [D27.505.696.663]
Autonomic Agents [D27.505.696.663.050]
Ganglionic Stimulants [D27.505.696.663.050.400]

Below are MeSH descriptors whose meaning is related to "Ganglionic Stimulants".

Below are MeSH descriptors whose meaning is more specific than "Ganglionic Stimulants".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ganglionic Stimulants" by people in Harvard Catalyst Profiles by year, and whether "Ganglionic Stimulants" was a major or minor topic of these publication.

Bar chart showing 15 publications over 9 distinct years, with a maximum of 3 publications in 2002

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	1	0	1
1998	1	0	1
1999	2	0	2
2000	1	1	2
2002	3	0	3
2003	1	1	2
2004	1	0	1
2005	2	0	2

Below are the most recent publications written about "Ganglionic Stimulants" by people in Profiles.

Commonly used stimulants: Sleep problems, dependence and psychological distress. Drug Alcohol Depend. 2015 Aug 01; 153:145-51.

View in: PubMed
The effects of nicotine on vascular smooth muscle cell chemotaxis induced by thrombospondin-1 and fibronectin. Am J Surg. 2011 Nov; 202(5):545-8.

View in: PubMed
Nicotine overrides DNA damage-induced G1/S restriction in lung cells. PLoS One. 2011 Apr 29; 6(4):e18619.

View in: PubMed
Shifting topographic activation and 5-HT1A receptor-mediated inhibition of dorsal raphe serotonin neurons produced by nicotine exposure and withdrawal. Eur J Neurosci. 2011 May; 33(10):1866-75.

View in: PubMed
Nicotine suppression of gustatory responses of neurons in the nucleus of the solitary tract. J Neurophysiol. 2006 Oct; 96(4):1877-86.

View in: PubMed
Comparing participants and nonparticipants recruited for an effectiveness study of nicotine replacement therapy. Ann Behav Med. 2005 Jun; 29(3):181-91.

View in: PubMed
Inmate exposure to secondhand smoke in correctional facilities and the impact of smoking restrictions. J Expo Anal Environ Epidemiol. 2005 May; 15(3):205-11.

View in: PubMed
Latent class typology of nicotine withdrawal: genetic contributions and association with failed smoking cessation and psychiatric disorders. Psychol Med. 2005 Mar; 35(3):409-19.

View in: PubMed
Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis. 2004 Dec; 25(12):2487-95.

View in: PubMed
Reducing tobacco addiction through tobacco product regulation. Tob Control. 2004 Jun; 13(2):132-5.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Nicotine Tob Res
Gen Pharmacol
Tob Control
Eur J Neurosci
Drug Alcohol Depend
Carcinogenesis
Ann Behav Med
Am J Surg
Am J Public Health
Am J Physiol